Search for: [Abstract = "Infectious complications are one of the most common sequelae among cancer patients receiving chemotherapy. The goal of this study was to determine whether any of the analyzed regimens\: DA, DAC, DAF affect the incidence, etiology and severity of infectious complications and subsequently their influence on treatment outcome in adult patients with newly diagnosed acute myeloid leukemia..This study was a part of the multicenter, randomized, phase III PALG AML 1\/2004 study. The main aim of this study was to evaluate the influence of a purine analog addition \(cladribine or frudarabine\) to standard induction regimens on complete remission rate and overall survival. If no contraindications were present and all inclusion criteria were fulfilled all patients were centrally randomized to receive one of the above three induction regimens. A cohort of 92 AML patients \(48 female and 44 male\) with a median age 39.6 years was analyzed in the Department of Hematology of the University Hospital in Cracow between 2004 and 2008. Data were obtained using the “Infectious Complications Form” and the patients disease history.Based on the analysis performed at the Department of Hematology infectious complications were found in every type of induction course. The lowest frequency of febrile episodes was reported in the DAC group \(p=0.005\), simultaneously this group was considered as the most traceable i"]

Number of results: 1